ArticleThe Journal of clinical investigation2004

Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.

Craig E Daniels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.